BiotechTube
Home/Keapstone Therapeutics/Ross McMaster
RM

Ross McMaster

Company Secretary, Board Member, Financial Consultant

Keapstone Therapeutics

Therapeutic Areas

Neurodegenerative DiseasesParkinson's DiseaseAmyotrophic Lateral Sclerosis (ALS)

Keapstone Therapeutics Pipeline

DrugIndicationPhase
Nrf2 Activator ProgramParkinson's DiseasePre-clinical

Leadership Team at Keapstone Therapeutics

DR
Dr Richard Mead
Co-Founder, Board Member, Senior Lecturer at SITraN
DP
Dame Professor Pamela Shaw
Co-Founder, Director of SITraN
AR
Arthur Roach
Board Member, Director of Research at Parkinson's UK
View full Keapstone Therapeutics profile